Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency.
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors.
Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
Month of birth as a risk factor for multiple sclerosis: an update.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Atomic view of a toxic amyloid small oligomer.
UCSF Neuroimmunology Seminar
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
Scoring treatment response in patients with relapsing multiple sclerosis.
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.
Cognitive dysfunction in multiple sclerosis.
Interventions to evaluate fitness to drive among people with chronic conditions: Systematic review of literature.
Effect of virtual reality-based balance training in multiple sclerosis.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Diffusion tensor imaging of the cervical spinal cord of patients with Neuromyelitis Optica.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
Multiple sclerosis: Phases of disease improvement unrelated to relapses.

Pages